CTA-Sticky-button.png clinicaltrialsyearbook+button
ctsnordics2017-header_v3.jpg

Clinical Trial Supply Nordics 2017

7-8 June, 2017, Copenhagen, Denmark

This event brings together leading professionals from the Nordics’ most innovative pharma and biotech companies. Following the success of our 2016 conference, the 4th Annual Clinical Trial Supply Nordics event will be returning in June with more content and senior level speakers than before.

The 2017 programme will host speakers from the likes of LEO Pharma, Novo Nordisk, GSK, Lundbeck, as well as a number of small to mid-sized biotechs. This two-day event will focus on the top issues facing the industry such as label simplification to improve efficiency and cold chain management for safeguarding products. These challenges will be addressed through interactive presentations and engaging panel discussions. There will also be stimulating roundtable discussions on both days, allowing attendees to debate possible solutions in smaller groups.

The event offers a perfect platform for collaborating and building relationships between sponsors and vendors to facilitate the formation of new partnerships and strengthening existing relationships.

CTS Nordics will be returning on June 7th & 8th 2017, we look forward to seeing you there!

Event News

What interactive, new sessions will the 2017 programme include?

We will have an engaging, joint presentation from Novo Nordisk identifying the changes in Annex 13 and how this will impact new labelling strategies. We will have a regulatory expert uncovering the benefits of exploring both regional and national regulations when working with new markets, to ensure all label requirements are met.

What did our 2016 delegates think?

This event brings together people with the most relevant and up to date knowledge-  Director, Quality, LEO Pharma

Clinical Trial Supply regulations, how can you ensure compliance?

With many regulations being updated or introduced to the clinical supply environment, the importance of staying up to date with these regulations and methods to ensure compliance has become crucial to success in the industry. Thus it is essential to limit these potential barriers in order to maintain an effective clinical supply chain.

The changing landscape in Clinical Trials, examine and learn at this year’s Clinical Trials Supply Nordics conference

As we enter into 2017, various changes in the industry have altered the landscape for clinical trial supply businesses.  With this in mind, our team has developed an extensive and informative agenda to ensure you leave with various concepts to improve your clinical trial supply chain in the ever changing environment.

AstraZeneca discusses how scientific data and a risk-based distribution strategy can lower the risk of temperature excursions

The conference opened with a presentation from Eva-Lotta Persson, Supply Chain Programme Manager at AstraZeneca, in which she highlighted how scientific data and a risk-based distribution strategy can lower the risk of temperature excursions and avoid wasted product within the clinical supply chain. The presentation began by summing up that Good Distribution Practice was about making sure the correct product of the correct quality reaches the patient on time. Then, Eva-Lotta went into ...

Thought-provoking, Interactive Sessions

Clinical Trial Supply Nordics 2016 had a host of interactive sessions based on providing delegates from companies of all-sizes practical take-aways to aid them in improving the efficiency of their local and global clinical supply chains.






300x250-Subscribe-for-updates-banner+version+2.jpg